Cover Image
市場調查報告書

傷口縫合設備:醫療設備的開發平台評估

Wound Closure Devices - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 579981
出版日期 內容資訊 英文 538 Pages
訂單完成後即時交付
價格
Back to Top
傷口縫合設備:醫療設備的開發平台評估 Wound Closure Devices - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年11月07日 內容資訊: 英文 538 Pages
簡介

本報告提供傷口縫合設備的開發中產品的相關調查,提供產品開發·臨床實驗的整體進展,及企業·各產品詳細趨勢(臨床實驗的進展,開始/結束時期,核准預測等),總括性彙整近幾年的開發·資本交易趨勢等資訊。

第1章 目錄

第2章 簡介

  • 傷口縫合設備概要

第3章 傷口縫合設備-開發中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:審查各級
  • 開發中產品:各預定核准時期
  • 現在進行中的臨床實驗

第4章 傷口縫合設備-正在開發的開發中產品:各企業

  • 傷口縫合設備企業:各開發階段的開發中產品
  • 傷口縫合設備:各開發階段的開發中產品

第5章 傷口縫合設備:企業及產品概要

  • 3-D Matrix Ltd
  • Actamax Surgical Materials LLC
  • Adhesys Medical GmbH
  • Advanced Medical Solutions Group plc
  • Alafair Biosciences Inc
  • Alumend LLC Company
  • Anika Therapeutics Inc
  • Arch Therapeutics Inc
  • Argon Medical Devices Inc
  • Aura Medsystems, Inc.
  • Baxter International Inc
  • Bayer HealthCare AG
  • Bergen Medical Products Inc
  • Beth Israel Deaconess Medical Center Inc
  • Biomedica Management Corp
  • Biom'Up SAS
  • Boston University
  • C. R. Bard Inc
  • Calmare Therapeutics Inc
  • CardioCommand Inc
  • Cellphire Inc
  • Ceramicos Para Aplicacoes Medicas Lda
  • Clemson University
  • Cohera Medical Inc
  • Columbia University
  • CorMedix Inc
  • Covalent Medical, Inc.
  • Covalon Technologies Ltd
  • Cresilon Inc
  • CryoLife Inc
  • CSMG Technologies, Inc.
  • Daewoong Pharmaceutical Co Ltd
  • Dermtreat ApS
  • DSM Biomedical BV
  • Emory University
  • Endomedix Incorporated
  • Entegrion Inc
  • Ethicon Endo-Surgery Inc
  • Ethicon US LLC
  • Gamma Therapeutics Inc
  • Gecko Biomedical
  • gel-e Inc
  • Grifols SA
  • Haemostatix Ltd
  • Hemostasis LLC
  • HyperBranch Medical Technology Inc
  • Innocoll Technologies Ltd
  • Institute of Molecular Biology of Parana
  • Integra LifeSciences Holdings Corp
  • InVivo Therapeutics Corp
  • IonMed Ltd.
  • John Hopkins University
  • KeraNetics, LLC
  • Kitotech Medical, Inc.
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • Kytogenics Pharmaceuticals Inc
  • Laser Tissue Welding, Inc.
  • Latch Medical Ltd
  • Lenvitz Medical Solutions Pvt. Ltd.
  • Life Care Medical Devices Limited
  • LifeBond Ltd
  • Maxigen Biotech Inc
  • Medisse BV
  • Medtronic plc
  • MLM Biologics Inc
  • Northwestern University
  • OptMed, Inc.
  • PetVivo Holdings Inc
  • Pharming Group NV
  • Polyganics BV
  • Protein Polymer Technologies Inc
  • Regenics AS
  • Resorba GmbH
  • Resultados y Calidad del Sistema Sanitario Publico de Andalucia
  • Rice University
  • Samyang Biopharmaceuticals Corp
  • Sanofi
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Seraffix Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Sheba Medical Center
  • St Teresa Medical Inc
  • Surgical Energetics LLC
  • Surgical Sealants, Inc.
  • TEIJIN FIBERS製藥
  • Texas A&M University
  • The Medicines Company
  • ThermoTek, Inc.
  • Therus Corporation
  • Thrombotargets Corp
  • Tribos LLC
  • Tricol Biomedical Inc
  • United Health Products, Inc.
  • University of Akron
  • University of Grenoble Alpes
  • University of Kansas
  • University of Toledo
  • Vigor Medical Technologies Ltd.
  • Virginia Commonwealth University
  • Wound Management Technologies Inc
  • WoundZipper Inc
  • Xcede Technologies Inc

第6章 傷口縫合設備:近幾年趨勢

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 聯絡處
  • 免責聲明

圖表清單

目錄
Product Code: GDME0487EPD

GlobalData's Medical Devices sector report, "Wound Closure Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 11
  • 1.2 List of Figures 21

2 Introduction 22

  • 2.1 Wound Closure Devices Overview 22

3 Products under Development 25

  • 3.1 Wound Closure Devices - Pipeline Products by Stage of Development 25
  • 3.2 Wound Closure Devices - Pipeline Products by Territory 26
  • 3.3 Wound Closure Devices - Pipeline Products by Regulatory Path 28
  • 3.4 Wound Closure Devices - Pipeline Products by Estimated Approval Date 29
  • 3.5 Wound Closure Devices - Ongoing Clinical Trials 30

4 Wound Closure Devices - Pipeline Products under Development by Companies 31

  • 4.1 Wound Closure Devices Companies - Pipeline Products by Stage of Development 31
  • 4.2 Wound Closure Devices - Pipeline Products by Stage of Development 35

5 Wound Closure Devices Companies and Product Overview 40

  • 5.1 3-D Matrix Ltd Company Overview 40
  • 5.2 Actamax Surgical Materials LLC Company Overview 44
  • 5.3 Adhesys Medical GmbH Company Overview 45
  • 5.4 Advanced Medical Solutions Group plc Company Overview 48
  • 5.5 Alafair Biosciences Inc Company Overview 53
  • 5.6 Alumend LLC Company Overview 54
  • 5.7 Anika Therapeutics Inc Company Overview 55
  • 5.8 Arch Therapeutics Inc Company Overview 56
  • 5.9 Argon Medical Devices Inc Company Overview 58
  • 5.10 Aura Medsystems, Inc. Company Overview 60
  • 5.11 Baxter International Inc Company Overview 61
  • 5.12 Bayer HealthCare AG (Inactive) Company Overview 66
  • 5.13 Bergen Medical Products Inc Company Overview 67
  • 5.14 Beth Israel Deaconess Medical Center Inc Company Overview 68
  • 5.15 Biomedica Management Corp Company Overview 69
  • 5.16 Biom'Up SAS Company Overview 72
  • 5.17 Boston University Company Overview 75
  • 5.18 C. R. Bard Inc Company Overview 76
  • 5.19 Calmare Therapeutics Inc Company Overview 81
  • 5.20 CardioCommand Inc Company Overview 82
  • 5.21 Cellphire Inc Company Overview 83
  • 5.22 Ceramicos Para Aplicacoes Medicas Lda Company Overview 85
  • 5.23 Clemson University Company Overview 86
  • 5.24 Cohera Medical Inc Company Overview 87
  • 5.25 Columbia University Company Overview 93
  • 5.26 CorMedix Inc Company Overview 94
  • 5.27 Covalent Medical, Inc. (Inactive) Company Overview 95
  • 5.28 Covalon Technologies Ltd Company Overview 97
  • 5.29 Cresilon Inc Company Overview 99
  • 5.30 CryoLife Inc Company Overview 101
  • 5.31 CSMG Technologies, Inc. (Inactive) Company Overview 104
  • 5.32 Daewoong Pharmaceutical Co Ltd Company Overview 105
  • 5.33 Dermtreat ApS Company Overview 110
  • 5.34 DSM Biomedical BV Company Overview 113
  • 5.35 Emory University Company Overview 114
  • 5.36 Endomedix Incorporated Company Overview 115
  • 5.37 Entegrion Inc Company Overview 117
  • 5.38 Ethicon Endo-Surgery Inc Company Overview 118
  • 5.39 Ethicon US LLC Company Overview 119
  • 5.40 Gamma Therapeutics Inc Company Overview 122
  • 5.41 Gecko Biomedical Company Overview 124
  • 5.42 gel-e Inc Company Overview 127
  • 5.43 Grifols SA Company Overview 129
  • 5.44 Haemostatix Ltd Company Overview 130
  • 5.45 Hemostasis LLC Company Overview 134
  • 5.46 HyperBranch Medical Technology Inc Company Overview 137
  • 5.47 Innocoll Technologies Ltd Company Overview 139
  • 5.48 Institute of Molecular Biology of Parana Company Overview 140
  • 5.49 Integra LifeSciences Holdings Corp Company Overview 141
  • 5.50 InVivo Therapeutics Corp Company Overview 144
  • 5.51 IonMed Ltd. Company Overview 145
  • 5.52 John Hopkins University Company Overview 147
  • 5.53 KeraNetics, LLC Company Overview 148
  • 5.54 Kitotech Medical, Inc. Company Overview 149
  • 5.55 Kollodis BioSciences Inc Company Overview 151
  • 5.56 Kuros Biosciences AG Company Overview 153
  • 5.57 Kytogenics Pharmaceuticals Inc Company Overview 155
  • 5.58 Laser Tissue Welding, Inc. Company Overview 156
  • 5.59 Latch Medical Ltd Company Overview 159
  • 5.60 Lenvitz Medical Solutions Pvt. Ltd. Company Overview 160
  • 5.61 Life Care Medical Devices Limited Company Overview 161
  • 5.62 LifeBond Ltd Company Overview 162
  • 5.63 Maxigen Biotech Inc Company Overview 168
  • 5.64 Medisse BV (Inactive) Company Overview 169
  • 5.65 Medtronic plc Company Overview 172
  • 5.66 MLM Biologics Inc Company Overview 174
  • 5.67 Northwestern University Company Overview 176
  • 5.68 OptMed, Inc. Company Overview 177
  • 5.69 PetVivo Holdings Inc Company Overview 180
  • 5.70 Pharming Group NV Company Overview 181
  • 5.71 Polyganics BV Company Overview 182
  • 5.72 Protein Polymer Technologies Inc (Inactive) Company Overview 188
  • 5.73 Regenics AS Company Overview 190
  • 5.74 Resorba GmbH Company Overview 192
  • 5.75 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 197
  • 5.76 Rice University Company Overview 198
  • 5.77 Samyang Biopharmaceuticals Corp Company Overview 199
  • 5.78 Sanofi Company Overview 201
  • 5.79 Sea Run Holdings Inc Company Overview 203
  • 5.80 Sealantis Ltd. Company Overview 205
  • 5.81 Seraffix Ltd Company Overview 207
  • 5.82 Shanghai Haohai Biological Technology Co Ltd Company Overview 208
  • 5.83 Sheba Medical Center Company Overview 210
  • 5.84 St Teresa Medical Inc Company Overview 211
  • 5.85 Surgical Energetics LLC Company Overview 213
  • 5.86 Surgical Sealants, Inc. Company Overview 214
  • 5.87 Teijin Pharma Ltd Company Overview 215
  • 5.88 Texas A&M University Company Overview 216
  • 5.89 The Medicines Company Company Overview 218
  • 5.90 ThermoTek, Inc. Company Overview 220
  • 5.91 Therus Corporation Company Overview 221
  • 5.92 Thrombotargets Corp Company Overview 222
  • 5.93 Tribos LLC Company Overview 224
  • 5.94 Tricol Biomedical Inc Company Overview 225
  • 5.95 United Health Products, Inc. Company Overview 226
  • 5.96 University of Akron Company Overview 229
  • 5.97 University of Grenoble Alpes Company Overview 230
  • 5.98 University of Kansas Company Overview 231
  • 5.99 University of Toledo Company Overview 232
  • 5.100 Vigor Medical Technologies Ltd. Company Overview 233
  • 5.101 Virginia Commonwealth University Company Overview 234
  • 5.102 Wound Management Technologies Inc Company Overview 235
  • 5.103 WoundZipper Inc Company Overview 236
  • 5.104 Xcede Technologies Inc Company Overview 237

6 Wound Closure Devices- Recent Developments 240

  • 6.1 Sep 20, 2017: Actamax receives approval to begin pivotal clinical trial for Actamax Adhesion Barrier 240
  • 6.2 Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update 240
  • 6.3 Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer 241
  • 6.4 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates 243
  • 6.5 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 244
  • 6.6 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma 244
  • 6.7 Sep 13, 2017: gel-e Expands Core Team with Regulatory, Manufacturing and Financial Talent 245
  • 6.8 Sep 12, 2017: Arch Therapeutics Reports Favorable Results in Repeat Dose Testing of AC5 for Subchronic Systemic Toxicity 245
  • 6.9 Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director 246
  • 6.10 Sep 11, 2017: Gecko Biomedical receives CE Mark Approval for SETALUM Sealant 247
  • 6.11 Sep 07, 2017: St. Teresa Medical Announces First Commercial Use of SURGICLOT in Auckland, New Zealand 247
  • 6.12 Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors 248
  • 6.13 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 249
  • 6.14 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 250
  • 6.15 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 251
  • 6.16 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 251
  • 6.17 Aug 22, 2017: United Health Products Reports Second Quarter 2017 Results 252
  • 6.18 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 252
  • 6.19 Aug 21, 2017: WoundZipper Earns Patent for Magnetic Non-Suture Wound Closure Device 254
  • 6.20 Aug 21, 2017: Covalon Releases Third Quarter Financial Results 255
  • 6.21 Aug 15, 2017: Multiple Postmarket Clinical Studies Nearing Completion in Europe, Supporting Broad Range of Applications for TissuGlu Surgical Adhesive 256
  • 6.22 Aug 10, 2017: Alliqua BioMedical Reports Second Quarter of Fiscal Year 2017 Financial Results 257
  • 6.23 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results 259
  • 6.24 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 262
  • 6.25 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 262
  • 6.26 Aug 02, 2017: United Health Products Reports Profitable First Quarter ended March 31, 2017 263
  • 6.27 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 264
  • 6.28 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 264
  • 6.29 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 266
  • 6.30 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER 266
  • 6.31 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 273
  • 6.32 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 273
  • 6.33 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 280
  • 6.34 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 281
  • 6.35 Jul 27, 2017: Stryker reports second quarter 2017 results 284
  • 6.36 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 285
  • 6.37 Jul 27, 2017: JustRight Surgical Announces New CEO 286
  • 6.38 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance 286
  • 6.39 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 289
  • 6.40 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 291
  • 6.41 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 292
  • 6.42 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 293
  • 6.43 Jul 25, 2017: Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5 Topical Gel 294
  • 6.44 Jul 24, 2017: Ergomed completes Phase IIb study recruitment six months ahead of schedule for its innovative coagulant PeproStat 295
  • 6.45 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 295
  • 6.46 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 297
  • 6.47 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 297
  • 6.48 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 299
  • 6.49 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range 299
  • 6.50 Jul 12, 2017: TissuGlu Surgical Adhesive facilitates drain-free mastectomy 300
  • 6.51 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 301
  • 6.52 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer 302
  • 6.53 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down 303
  • 6.54 Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 304
  • 6.55 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 304

7 Appendix 533

  • 7.1 Methodology 533
  • 7.2 About GlobalData 536
  • 7.3 Contact Us 536
  • 7.4 Disclaimer 536

List of Tables

  • Table 1: Wound Closure Devices - Pipeline Products by Stage of Development 27
  • Table 2: Wound Closure Devices - Pipeline Products by Territory 29
  • Table 3: Wound Closure Devices - Pipeline Products by Regulatory Path 30
  • Table 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date 31
  • Table 5: Wound Closure Devices - Ongoing Clinical Trials 32
  • Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development 33
  • Table 8: Wound Closure Devices - Pipeline Products by Stage of Development 37
  • Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 10: PuraStat Hemostat - Product Status 42
  • Table 11: PuraStat Hemostat - Product Description 43
  • Table 12: TDM-511 - Product Status 43
  • Table 13: TDM-511 - Product Description 43
  • Table 14: 3-D Matrix Ltd - Ongoing Clinical Trials Overview 44
  • Table 15: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 45
  • Table 16: PuraStat Hemostat - Randomized Controlled Trial Comparing Purastat to Standard Therapy for Haemostasis Control During Endoscopic Submucosal Dissection 45
  • Table 17: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 18: Actamax Adhesion Barrier - Product Status 46
  • Table 19: Actamax Adhesion Barrier - Product Description 46
  • Table 20: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 21: CUTIS - Product Status 47
  • Table 22: CUTIS - Product Description 47
  • Table 23: Tissue Adhesive - Pancreatectomy - Product Status 48
  • Table 24: Tissue Adhesive - Pancreatectomy - Product Description 48
  • Table 25: VIVO - Product Status 48
  • Table 26: VIVO - Product Description 49
  • Table 27: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 28: LiquiBand - Product Status 50
  • Table 29: LiquiBand - Product Description 50
  • Table 30: LiquiBand Exceed - Product Status 51
  • Table 31: LiquiBand Exceed - Product Description 51
  • Table 32: LiquiBand Flow Control - Product Status 51
  • Table 33: LiquiBand Flow Control - Product Description 52
  • Table 34: Next Generation Internal Fixation And Sealant Device - Product Status 52
  • Table 35: Next Generation Internal Fixation And Sealant Device - Product Description 52
  • Table 36: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 53
  • Table 37: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery 54
  • Table 38: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 39: VersaWrap Adhesion Barrier - Product Status 55
  • Table 40: VersaWrap Adhesion Barrier - Product Description 55
  • Table 41: Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 42: Tissue-Bonding Adhesive - Product Status 56
  • Table 43: Tissue-Bonding Adhesive - Product Description 56
  • Table 44: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 45: Hemostatic Patch - Product Status 57
  • Table 46: Hemostatic Patch - Product Description 57
  • Table 47: Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 48: AC5 Surgical Hemostatic Device - Product Status 58
  • Table 49: AC5 Surgical Hemostatic Device - Product Description 58
  • Table 50: AC5 Surgical Hemostatic Device - Internal Use - Product Status 59
  • Table 51: AC5 Surgical Hemostatic Device - Internal Use - Product Description 59
  • Table 52: Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 53: Hemaseel HMN Fibrin Sealant - Product Status 60
  • Table 54: Hemaseel HMN Fibrin Sealant - Product Description 60
  • Table 55: Hemaseel Thrombin Haemostatic Agent - Product Status 61
  • Table 56: Hemaseel Thrombin Haemostatic Agent - Product Description 61
  • Table 57: Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 58: LaSTR - Skin Closure Device - Product Status 62
  • Table 59: LaSTR - Skin Closure Device - Product Description 62
  • Table 60: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 61: Hemopatch - Product Status 63
  • Table 62: Hemopatch - Product Description 64
  • Table 63: Tisseel Dura - Product Status 64
  • Table 64: Tisseel Dura - Product Description 64
  • Table 65: Baxter International Inc - Ongoing Clinical Trials Overview 65
  • Table 66: Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL) 66
  • Table 67: Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant 66
  • Table 68: Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection 66
  • Table 69: Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial 67
  • Table 70: Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH 67
  • Table 71: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 72: Polyurethane Adhesive System - Product Status 68
  • Table 73: Polyurethane Adhesive System - Product Description 68
  • Table 74: Bergen Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 75: ACTACLOSE - Product Status 69
  • Table 76: ACTACLOSE - Product Description 69
  • Table 77: Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 78: Portable Wound Hemostasis System - Product Status 70
  • Table 79: Portable Wound Hemostasis System - Product Description 70
  • Table 80: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 81: ClotBlock - Product Status 71
  • Table 82: ClotBlock - Product Description 71
  • Table 83: ClotFoam - Product Status 72
  • Table 84: ClotFoam - Product Description 72
  • Table 85: ClotGel - Product Status 72
  • Table 86: ClotGel - Product Description 73
  • Table 87: ClotSpray - Product Status 73
  • Table 88: ClotSpray - Product Description 73
  • Table 89: Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 90: Hemoblast Bellows - Product Status 74
  • Table 91: Hemoblast Bellows - Product Description 74
  • Table 92: Biom'Up SAS - Ongoing Clinical Trials Overview 75
  • Table 93: Hemoblast Bellows - Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of Hemoblast Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries 76
  • Table 94: Boston University Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 95: Hydrogel-based Aerosolized Sealant Dressing - Product Status 77
  • Table 96: Hydrogel-based Aerosolized Sealant Dressing - Product Description 77
  • Table 97: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 98: New Hemostat 1 - Product Status 78
  • Table 99: New Hemostat 1 - Product Description 79
  • Table 100: New Hemostat 2 - Product Status 79
  • Table 101: New Hemostat 2 - Product Description 79
  • Table 102: Progel Dural Sealant - Product Status 80
  • Table 103: Progel Dural Sealant - Product Description 80
  • Table 104: Progel Emerald - Product Status 80
  • Table 105: Progel Emerald - Product Description 81
  • Table 106: ProGEL-VS - Product Status 81
  • Table 107: ProGEL-VS - Product Description 81
  • Table 108: Tridyne Peripheral - Product Status 82
  • Table 109: Tridyne Peripheral - Product Description 82
  • Table 110: Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 111: Wound Sealant - Product Status 83
  • Table 112: Wound Sealant - Product Description 83
  • Table 113: CardioCommand Inc Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 114: Tournicath Device - Product Status 84
  • Table 115: Tournicath Device - Product Description 84
  • Table 116: Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 117: Thromboderm - Product Status 85
  • Table 118: Thromboderm - Product Description 85
  • Table 119: Thrombosomes - Hemostatic Agent - Product Status 86
  • Table 120: Thrombosomes - Hemostatic Agent - Product Description 86
  • Table 121: Ceramicos Para Aplicacoes Medicas Lda Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 122: HemoKi - Product Status 87
  • Table 123: HemoKi - Product Description 87
  • Table 124: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 125: Surgical Adhesive Hydrogel - Product Status 88
  • Table 126: Surgical Adhesive Hydrogel - Product Description 88
  • Table 127: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 128: Sylys Surgical Sealant - Product Status 89
  • Table 129: Sylys Surgical Sealant - Product Description 90
  • Table 130: Sylys Surgical Sealant - Drug Delivery - Product Status 90
  • Table 131: Sylys Surgical Sealant - Drug Delivery - Product Description 90
  • Table 132: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 91
  • Table 133: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 91
  • Table 134: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 91
  • Table 135: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 92
  • Table 136: Cohera Medical Inc - Ongoing Clinical Trials Overview 93
  • Table 137: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 94
  • Table 138: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant 94
  • Table 139: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 95
  • Table 140: Hemostatic Wound Dressing - Product Status 95
  • Table 141: Hemostatic Wound Dressing - Product Description 95
  • Table 142: CorMedix Inc Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 143: Taurolidine Wound Closures - Product Status 96
  • Table 144: Taurolidine Wound Closures - Product Description 96
  • Table 145: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 146: Covabond - Product Status 97
  • Table 147: Covabond - Product Description 97
  • Table 148: CovaSTAT - Product Status 98
  • Table 149: CovaSTAT - Product Description 98
  • Table 150: Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

List of Figures

  • Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development 27
  • Figure 2: Wound Closure Devices - Pipeline Products by Territory 28
  • Figure 3: Wound Closure Devices - Pipeline Products by Regulatory Path 30
  • Figure 4: Wound Closure Devices - Pipeline Products by Estimated Approval Date 31
  • Figure 5: Wound Closure Devices - Ongoing Clinical Trials 32
Back to Top